Schedule 13G ownership disclosure

Evofem Biosciences Operations, Inc.

Security class unavailable · CUSIP: 30048L104

Event date: 2019-07-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-19-014930
Form type
SC 13G/A
Filer
Evofem Biosciences, Inc.
CIK
CIK 1618835
Filed
Aug 08, 2019
Reporting period
Jul 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub